Reading aloud The first patient with the new revolutionary artificial heart AbioCor in the chest, according to his doctors, is doing well according to the circumstances. He sits upright in bed and talks to his family, according to an official statement from the Louisville Jewish University Hospital (Kentucky) from night to Friday. According to his doctor Laman Gray, the worst would be over if he did not suffer a setback by Sunday. The artificial heart AbioCor can completely replace the body's own organ and has no wires or hoses to the outside. It is made of titanium, is about the size of a man's fist and weighs just under a kilogram without wires and tubes.

According to Gray, the patient is a man in his mid-fifties. He also suffered from diabetes and chronic kidney failure and had multiple heart attacks. His chances to live another month or more were about twenty percent. The US Food and Drug Administration (FDA) has mandated physicians to select patients with a life expectancy of less than thirty days. With the artificial heart the unspecified patient should double his lifetime to at least sixty days.



Recommended Editor'S Choice